What is Evernow?
Evernow operates at the intersection of health technology and women's wellness, specifically targeting the underserved market of menopause care. Founded in 2019, the company utilizes a telemedicine-first approach to provide symptomatic women with accessible, evidence-based hormone therapy and personalized treatment plans. By digitizing the clinical assessment process, Evernow removes traditional barriers to care, offering a streamlined, patient-centric experience that addresses the physiological complexities of menopause. The company's market position is defined by its commitment to clinical rigor and its ability to scale specialized medical services through a robust digital infrastructure.
How much funding has Evernow raised?
Evernow has raised a total of $28.5M across 1 funding round:
Series A
$28.5M
Series A (2022): $28.5M with participation from New Enterprise Associates, Gwyneth Paltrow, Carla Harris, Cameron Diaz, Refactor Capital, Coelius Capital, Drew Barrymore, Othman Laraki, and 8VC
Key Investors in Evernow
New Enterprise Associates
Established in 1977, New Enterprise Associates is a prominent venture capital firm that partners with entrepreneurs to build transformative businesses across various sectors.
Refactor Capital
Refactor Capital is an early-stage venture firm dedicated to supporting founders who are solving fundamental human problems through hard tech and innovative business models.
8VC
8VC is a technology-focused investment firm that manages significant committed capital, specializing in backing visionary teams within the healthcare, Bio-IT, and enterprise platform sectors.
What's next for Evernow?
With the recent influx of capital, Evernow is poised to scale its operations, expand its clinical reach, and further refine its diagnostic algorithms. The company's strategic roadmap likely includes enhancing its telemedicine platform to support a broader range of symptoms and integrating more sophisticated data analytics to improve patient outcomes. As the firm continues to navigate the competitive landscape of digital health, the focus will remain on building long-term trust with its user base while maintaining the high standards of care that have attracted significant institutional support. Future growth will be driven by the continued adoption of virtual care models and the ongoing expansion of its specialized medical network.
See full Evernow company page
